Brain imaging study for Parkinson's and related disorders
Part of Brain & nervous system clinical trials.
This study uses brain imaging and tests to better understand Parkinson's disease and related conditions. It aims to improve diagnosis by comparing scans across different groups of people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 85 years old
- Have a diagnosis of Parkinson's disease, multiple system atrophy (MSA), progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), or be a healthy volunteer
- Be willing to give written consent (or have a legal representative and a study partner)
- Not be pregnant or breastfeeding
- Be able to safely undergo MRI (no implanted devices like pacemakers)
- Agree to donate your brain after death (unless you are a healthy volunteer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special imaging tracer to see how it moves through the body and brain. It may help researchers understand brain changes in Parkinson's disease and related conditions.
This trial uses a special PET scan to see how a new imaging agent (called 11C-M503) travels through the body and brain. It may help researchers better understand brain conditions like Parkinson's disease.
This study uses a special PET scan to see how a new tracer (18F-JSS20-183A) moves through the body and brain. It may help researchers learn more about brain diseases like Parkinson's and Alzheimer's.
This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.
This study uses a special PET/CT brain scan to look at a protein called tau in people with memory/thinking and movement disorders. The results may help researchers understand how these diseases affect the brain and improve future diagnosis or care.
This trial studies how tau (a protein linked to Alzheimer’s and related conditions) shows up on a special brain scan called tau PET. It also uses MRI and blood work to understand brain changes and who may be at risk, helping researchers improve future diagnosis.
Hear when a new Tauopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.